Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission
2020-001474-29Phase 2Completed
- Sponsor
- Clínica Universidad de Navarra
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Clínica Universidad de Navarra. Primary endpoint: Proportion of patients with positive SARS-CoV-2 PCR from nasopharyngeal swab at day 7. Started May 2020; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001474-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001474-29.